Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule ...
Scientists have long studied the role of dopamine, a chemical in the brain that helps control learning and movement, in order ...
Deep brain stimulation (DBS) has emerged as a standard of care in the treatment of Parkinson’s disease and other movement disorders, such as dystonia and ...
An immune-related gene has now been tied to a rare inherited neurological disorder, revealing an overlooked pathway in the ...
This ‘3 am wake-up’ is more common than people think. It is also not random. Sleep experts say it is the result of a complex ...
How does dopamine control both movement and learning? New research reveals that acetylcholine acts as a "switch" for dopamine ...
Children presenting with abnormal tone and involuntary movements are a routine part of paediatric practice.
Dietitian Abbey Sharp was named by the "Biggest Loser" trainer during a debate with body positivity advocates on the platform ...
Parkinson's disease is a neurodegenerative disorder characterized by the progressive loss of dopamine-producing nerve cells in the brain, leading to motor slowing, gait and balance problems ...
Differing perspectives among gastric motility experts and regulatory roadblocks impede clinical care, but some companies are ...
Among women with more than 10 hours/day of sedentary behavior or less than 5 hours/day of light-intensity physical activity, risk increased exponentially.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results